- 1. Om programmet
- 2. Om utlysningen
- 3. Opprett søknad
| Frist | Utlysning | |
|---|---|---|
|
13.02.2013 13:00 CET |
Support for events | Velg |
|
13.02.2013 13:00 CET |
Approximately NOK 60 million available for Innovation Projects for the Industrial Sector | Velg |
|
05.09.2012 13:00 CET Gjennomført |
Arrangementstøtte | Velg |
|
19.04.2012 13:00 CET Gjennomført |
NOK 160 mill. to global health and vaccination research – Call for full proposals | Velg |
|
30.11.2011 13:00 CET Gjennomført |
160 millioner kroner til global helse- og vaksinasjonsforskning | Velg |
|
04.06.2009 13:00 CET Gjennomført |
Global vaksinasjonsforskning 2009 - generell og norsk-indisk utlysning | Velg |
|
03.09.2008 12:00 CET Gjennomført |
Vaccination research 2008 part I - general call | Velg |
|
03.09.2008 12:00 CET Gjennomført |
Vaccination research 2008 part II: Norwegian-Indian joint call | Velg |
|
16.04.2008 12:00 CET Gjennomført |
Project establishment support | Velg |
|
06.06.2007 18:00 CET Gjennomført |
Call for proposals on vaccination research 2007 | Velg |
|
06.06.2007 18:00 CET Gjennomført |
Joint call for proposals: Norwegian-Indian collaboration on human vaccination research 2007 | Velg |
|
06.06.2007 18:00 CET Gjennomført |
Support to organize conferences/workshops/seminars in global health and vaccination research 2007 | Velg |
|
18.04.2007 18:00 CET Gjennomført |
Call for proposals on global health research 2007 | Velg |
|
31.08.2006 18:00 CET Gjennomført |
2006 FIRST CALL FOR PROPOSALS for Vaccination Research programme | Velg |
|
15.06.2005 18:00 CET Gjennomført |
Utlysning av forskerprosjekter for 2006 | Velg |
|
01.04.2004 18:00 CET Gjennomført |
Utlysning av forskningsmidler for 2004 | Velg |
Mål for programmet:
The primary objective of the Programme for Global Health and Vaccination Research (GLOBVAC) is to support high-quality research with potential for high impact that can contribute to sustainable improvements in health and health equity for poor people in low- and lower-middle income countries (LMIC).
Please note that low- and lower-middle income countries are defined in accordance with the OECD DAC list covering the following categories: least developed countries, other low-income countries, and lower middle-income countries and territories.
If other aspects of competing applications are considered equal, priority will currently be given to the African countries of Burundi, Ethiopia, Liberia, Madagascar, Malawi, Mali, Mozambique, Sudan, South Sudan, Tanzania, Uganda and Zambia; the Asian countries of Afghanistan, Nepal, Pakistan, Sri Lanka and East Timor; and the Palestinian Territories in the Middle East.
However, projects directed at other low- and lower-middle income countries are also encouraged.
Secondary objectives of the Programme are to:
- develop and support internationally competitive and sustainable public and private research groups and institutions in Norway;
- develop and support national and international research collaboration and partnerships;
- secure capacity building through developing and supporting partnerships with research groups and institutions in low- and lower-middle-income countries;
- inform and increase awareness among policymakers, researchers and the public about needs for and results from global health research.
The Programme prioritises projects in the following thematic areas:
1. Vaccine and vaccination research: all aspects of vaccine research, including epidemiology, diagnostics, discovery/vaccine design, development, evaluation/testing of vaccines, and delivery/implementation of vaccination strategies. In particular, research that can lead from pre-clinical to clinical testing, and participation in international product development, is encouraged. Examples of relevant research areas could be tuberculosis, HIV, MenA, diarrheal diseases and HPV.
2. Health systems and health policy research: i.e. production and application of knowledge to improve how societies organize themselves in order to achieve health goals and research on human resources, health services and health information systems.
3. Innovation in technology and methods development and innovation for the development of technology and methods that can contribute to meet the needs for patients and health personnel in resource-constrained conditions in low- and-lower middle-income countries where appropriate technologies are not available or non-existing. This includes developing products of high quality for prevention, diagnosis and treatment that are appropriate, accessible and affordable in resource-constrained conditions.
4. Implementation research: research on the promotion of uptake of research findings into public health programmes, and to expand knowledge on strategies for implementation and wider scaling-up of effective health interventions and health services. Research must be based upon and linked to health implementation activities in low-and lower-middle income countries.
For all thematic areas:
Potential synergies with the Norwegian Programme for Capacity Building in Higher Education and Research for Development (NORHED) are desirable, and should be explained in research proposals.
For further information about the GLOBVAC Programme, please see the Work Programme 2012-2020 in the menu.
Generelt mottar programmet/aktiviteten søknad fra:
Public Norwegian research institutions, private and independent Norwegian research institutions and Norwegian companies.
Varighet:
2012-2020
Totalbudsjett:
The annual budget of the Programme is currently NOK 70.5 million.
Se også
Vedlegg
- Work programme (GLOBVAC) 2012-2020 (PDF-213 KB)
Kontaktpersoner
- Lars Petter Korsnes Seniorrådgiver lpk@forskningsradet.no
- Unni Hirdman Rørslett Seniorrådgiver 22 03 72 77 urh@forskningsradet.no
- Åse Marit Kristiansen Rådgiver 22 03 70 17 amk@forskningsradet.no
- Karine Kålsås Konsulent 22 03 74 02 kka@forskningsradet.no
